These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28646641)

  • 61. Do hospital mergers increase hospital efficiency? Evidence from a National Health Service country.
    Kjekshus L; Hagen T
    J Health Serv Res Policy; 2007 Oct; 12(4):230-5. PubMed ID: 17925075
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evolving patterns in a collaboration network of global R&D on monoclonal antibodies.
    Kong X; Wan JB; Hu H; Su S; Hu Y
    MAbs; 2017 Oct; 9(7):1041-1051. PubMed ID: 28737444
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Open innovation: A paradigm shift in pharma R&D?
    Schuhmacher A; Gassmann O; Bieniok D; Hinder M; Hartl D
    Drug Discov Today; 2022 Sep; 27(9):2395-2405. PubMed ID: 35643258
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Future pharmaceutical research: the need to look beyond science.
    Seeger S
    Future Med Chem; 2014 May; 6(7):721-3. PubMed ID: 24941866
    [No Abstract]   [Full Text] [Related]  

  • 65. Value networks identify innovation in 21st century pharmaceutical research.
    Edwards PJ
    Drug Discov Today; 2009 Jan; 14(1-2):68-77. PubMed ID: 18973823
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Drug discovery and development 2014: Returning toward the norm?
    Baldwin JJ
    Future Med Chem; 2015; 7(7):841-4. PubMed ID: 26061103
    [No Abstract]   [Full Text] [Related]  

  • 67. Consolidations and closures: an empirical analysis of exits from the hospital industry.
    Harrison TD
    Health Econ; 2007 May; 16(5):457-74. PubMed ID: 17031782
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Are mega-mergers good medicine for the pharmaceutical industry?
    Gershon D
    Nature; 2000 May; 405(6783):257-8. PubMed ID: 10821288
    [No Abstract]   [Full Text] [Related]  

  • 69. The Who, What, and Why of Drug Discovery and Development.
    Hogan G; Tangney M
    Trends Pharmacol Sci; 2018 Oct; 39(10):848-852. PubMed ID: 30196936
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recent trends in interorganizational deal networks in pharmaceutical and biotechnology industries.
    Yashiro K; Lim Y; Sengoku S; Kodama K
    Drug Discov Today; 2023 Mar; 28(3):103483. PubMed ID: 36584874
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Brazil: An emerging partner in drug R&D.
    Rodrigues DG
    IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A new application of value-stream mapping in new drug development: a case study within Novartis.
    Heinzen M; Mettler S; Coradi A; Boutellier R
    Drug Discov Today; 2015 Mar; 20(3):301-5. PubMed ID: 25448754
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Protection of Patients Under the Clayton Act.
    Kraus ES
    Fordham Law Rev; 2018 Apr; 86(5):2473-509. PubMed ID: 29993208
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Open innovation: public-private partnerships in pharmaceutical R&D].
    Uchibayashi N
    Nihon Yakurigaku Zasshi; 2013 Jul; 142(1):32-8. PubMed ID: 23842226
    [No Abstract]   [Full Text] [Related]  

  • 75. Lessons from a Recovering Academic.
    Ehlers MD
    Cell; 2016 May; 165(5):1043-1048. PubMed ID: 27203106
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Outsourcing chemical synthesis in the drug discovery process.
    Festel G
    Drug Discov Today; 2011 Mar; 16(5-6):237-43. PubMed ID: 21262378
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmaceutical R&D: the road to positive returns.
    David E; Tramontin T; Zemmel R
    Nat Rev Drug Discov; 2009 Aug; 8(8):609-10. PubMed ID: 19644471
    [No Abstract]   [Full Text] [Related]  

  • 78. Impact of hospital mergers on staff job satisfaction: a quantitative study.
    Lim KK
    Hum Resour Health; 2014 Dec; 12():70. PubMed ID: 25495151
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Decomposition of potential efficiency gains from hospital mergers in Greece.
    Flokou A; Aletras V; Niakas D
    Health Care Manag Sci; 2017 Dec; 20(4):467-484. PubMed ID: 27068659
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Decision-making in product portfolios of pharmaceutical research and development--managing streams of innovation in highly regulated markets.
    Jekunen A
    Drug Des Devel Ther; 2014; 8():2009-16. PubMed ID: 25364229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.